Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility Phenomenon
We propose a method for using results from magnetic resonance imaging (MRI) scans to guide targeted treatment of visible prostate cancer lesions. This will help to ensure accurate coverage and eradication of all of the cancer while minimising side effects.
Authors
- Caroline M. Moore (ORCID: https://orcid.org/0000-0003-0202-7912)
- Mark Emberton
- Louise Dickinson (ORCID: https://orcid.org/0009-0009-5703-5742)
- Francesco Giganti (ORCID: https://orcid.org/0000-0001-5218-6431)
- Joseph M. Norris (ORCID: https://orcid.org/0000-0003-2294-0303)
- Teresa Marsden (ORCID: https://orcid.org/0000-0002-1800-3547)
- S. Waigankar (ORCID: https://orcid.org/0000-0001-7586-5955)
- Arnauld Villers (ORCID: https://orcid.org/0000-0002-6298-7758)
- Clément Orczyk (ORCID: https://orcid.org/0000-0003-3067-2409)
- Alex Freeman (ORCID: https://orcid.org/0000-0001-5031-3791)
- Shonit Punwani (ORCID: https://orcid.org/0000-0002-1014-0870)
- Aiman Haider (ORCID: https://orcid.org/0000-0002-7005-4245)
- Alex Kirkham
- Clare Allen
Institutions
- University College London Hospitals NHS Foundation Trust (GB)
- Centre Hospitalier Universitaire de Lille (FR)
- University College London (GB)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.euros.2025.01.010
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research UK
- Norsk institutt for naturforskning
- Medical Research Council